SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 25, 2018
DOLBY LABORATORIES, INC.
(Exact name of registrant as specified in its charter)
(State or other jurisdiction
1275 Market Street
San Francisco, CA 94103-1410
(Address of principal executive offices) (Zip Code)
(Registrants telephone number, including area code) (415) 558-0200
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|☐||Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)|
|☐||Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)|
|☐||Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))|
|☐||Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Section 8 Other Events
|ITEM 8.01||Other Events|
A statement from the Board of Directors of Dolby Laboratories, Inc. regarding the passing of Board member Nicholas Donatiello, Jr. is attached as Exhibit 99.1 to this Current Report on Form 8-K.
Section 9 Financial Statements and Exhibits
|ITEM 9.01||Financial Statements and Exhibits.|
|99.1||Statement of the Board of Directors of Dolby Laboratories, Inc. dated June 29, 2018|
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|DOLBY LABORATORIES, INC.|
|By:||/s/ ANDY SHERMAN|
Executive Vice President, General Counsel, and Corporate Secretary
Date: June 29, 2018
Statement by Dolby Laboratories, Inc.s Board of Directors
Regarding the Passing of Nicholas Donatiello, Jr.
SAN FRANCISCO, June 29, 2018 (NYSE: DLB) It is with deep sadness that we announce the passing of Nicholas Donatiello, Jr., our fellow Board member at Dolby Laboratories, Inc. Nick was an industry leader and close friend who will be greatly missed by his colleagues at Dolby, its stockholders and business partners. Our thoughts and prayers are with his family during this difficult time.
Nick was a dear friend, a valued member of Dolbys board, and a distinguished voice in the field of corporate governance, said Peter Gotcher, Chairman of Board of Directors of Dolby Laboratories. We are deeply grateful for his many years of service, advice, and contributions to the company and its stockholders.
Mr. Donatiello was a member of the Board of Directors since 2009 and served as the Chairman of the Compensation Committee and a member of the Nominating and Governance Committee and the Technology Strategy Committee.
About Dolby Laboratories
Dolby Laboratories (NYSE: DLB) is based in San Francisco with offices in over 20 countries around the globe. Dolby transforms the science of sight and sound into spectacular experiences. Through innovative research and engineering, we create breakthrough experiences for billions of people worldwide through a collaborative ecosystem spanning artists, businesses, and consumers. The experiences people have - in Dolby Vision, Dolby Atmos, Dolby Cinema, Dolby Voice, and Dolby Audio - revolutionize entertainment and communications at the cinema, on the go, in the home, and at work.